Published in Anti-Infectives Week, November 23rd, 2009
"We completed the third quarter with a solid cash position and increased product revenues," said Louis Drapeau, InSite Vision's Chief Executive Officer. "AzaSite sales have been growing steadily through the efforts of our partner Inspire Pharmaceuticals, and beginning in the third quarter, our royalty rate on AzaSite increased by five percent to 25 percent. In addition, this year we have conserved fiscal resources, significantly reducing our costs as...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Anti-Infectives Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.